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SCIENTIFIC OPINION 
Scientific Opinion on a notification (reference C/NL/09/02) for the placing 
on the market of the genetically modified carnation IFD-26407-2 with a 
modified colour, for import of cut flowers for ornamental use, under Part C 
of Directive 2001/18/EC from Florigene
1
 
EFSA Panel on Genetically Modified Organisms (GMO)
2,3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Genetically modified (GM) carnation IFD-26407-2 was developed to express anthocyanins in the petals 
conferring a mauve colour to the flowers. The GM carnation is intended to be imported in the European Union as 
cut flower for ornamental use only. Based on the molecular characterisation data, the Scientific Panel on 
Genetically Modified Organisms of the European Food Safety Authority (EFSA GMO Panel) confirms the 
stability of the newly introduced trait and the absence of disruption of known endogenous genes. Since 
anthocyanins are common pigments in many food plants, it is not expected that accidental intake of petals of 
carnation IFD-26407-2 would contribute substantially to the overall intake of anthocyanins from foods. 
Considering the ornamental use of cut flowers, and the limited exposure scenarios expected, the EFSA GMO 
Panel identified no reasons for any food safety concerns relating to carnation IFD-26407-2. The EFSA GMO 
Panel is also of the opinion that accidental release of GM carnations into the environment would not give rise to 
environmental safety concerns. The EFSA GMO Panel agrees with the methodology, including reporting 
intervals, proposed for post-market environmental monitoring. In response to the European Commission, the 
EFSA GMO Panel concludes that, in the light of the ornamental use of carnation IFD-26407-2 cut flowers, there 
is no scientific reason to consider that the placing on the market of the GM carnation will cause any adverse 
effects on human health or the environment. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following a request from the European Commission, the Scientific Panel on Genetically Modified 
Organisms of the European Food Safety Authority (EFSA GMO Panel) was asked to deliver a 
scientific opinion on notification C/NL/09/02 from Florigene submitted under Part C of Directive 
2001/18/EC
4
. The scope of notification C/NL/09/02 covers the import, distribution and retailing in the 
European Union (EU) of genetically modified (GM) carnation IFD-26407-2 cut flowers for 
ornamental use only. 
In accordance with Directive 2001/18/EC, an assessment of the GM carnation was requested by the 
European Commission in order to address the outstanding objections raised by some Member States 
following the evaluation at the national level and to assess the overall safety of the GM carnation. The 
EFSA GMO Panel was, therefore, asked to consider if there is any scientific reason to believe that the 
placing on the market of the GM carnation IFD-26407-2 for import is likely to cause any adverse 
effects on human health or the environment. 
In delivering the present scientific opinion, the EFSA GMO Panel considered the full notification 
C/NL/09/02, including additional information provided by the notifier, the assessment report of the 
Dutch competent authority, the concerns raised by Member States, relevant scientific publications and 
the experience gained in assessing GM carnations with similar traits (EFSA, 2006a, 2008; EFSA 
GMO Panel, 2014). The EFSA GMO Panel performed its risk assessment in accordance with the 
principles of its guidance documents on the risk assessment of GM plants for non-food or non-feed 
purposes (EFSA, 2009a) and on the environmental risk assessment of GM plants (EFSA GMO Panel, 
2010). It should be noted that the comparative compositional assessment as defined in the EFSA 
guidance documents (EFSA, 2006b; EFSA GMO Panel, 2011a) could not be applied to identify 
possible unintended effects of carnation IFD-26407-2. 
The scientific evaluation by the EFSA GMO Panel included molecular characterisation of the inserted 
DNA and expression of the new proteins. A comparative evaluation of the morphological 
characteristics was undertaken, and the safety of the newly expressed proteins and of the whole GM 
plant was evaluated with respect to potential toxicity and allergenicity. The potential environmental 
impacts of accidental release of GM carnations into the environment and the post-market 
environmental monitoring (PMEM) plan proposed by the notifier were evaluated in the context of the 
scope of notification C/NL/09/02. 
Carnation IFD-26407-2 has a modified flower colour, a shade of mauve, whereas the parental line has 
a cerise flower colour. The colour has been achieved by introducing into the parental carnation two 
expression cassettes which, together with other genes of the anthocyanin biosynthesis pathway already 
present in the non-GM carnation, give rise to the anthocyanins delphinidin and cyanidin, the same 
compounds that give colour to blueberry, blackcurrant and red grape. Carnation IFD-26407-2 is also 
tolerant to sulfonylurea herbicides, but this newly introduced trait was used only for the selection of 
transformed plants and not for plant protection purposes. 
Carnation IFD-26407-2 was developed by Agrobacterium tumefaciens-mediated transformation of 
conventional carnation Cerise Westpearl. The desired colour was obtained by introducing the 
cytochrome b5 (cytb5) and flavonoid 3′,5′-hydroxylase (f3′5′h) coding sequences from Petunia sp. 
Tolerance to sulfonylurea herbicides was conferred by the expression of a mutated als gene. The 
molecular characterisation data establish that carnation IFD-26407-2 contains a single insert consisting 
of the three expression cassettes. The stability of the newly introduced trait (mauve flower colour) was 
observed over multiple generations. Bioinformatic analyses of the 5′ and 3′ flanking regions of the 
insert did not reveal disruption of known endogenous genes. Identities with allergens were found in 
putative translation products of open reading frames (ORFs) newly created by the genetic 
                                                     
4 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the 
environment of genetically modified organisms and repealing Council Directive 90/220/EEC. OJ L 106, 17.4.2001, p. 1–
39.  
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modification, but the likelihood that they are both transcribed and translated in carnation IFD-26407-2 
was considered negligible. 
Considering the scope of the notification and focusing on the limited information provided by the 
notifier, the EFSA GMO Panel is of the opinion that the altered flower colour and the differences 
observed for some morphological characteristics are not expected to influence the risk scenario of 
accidental intake of the GM carnation. 
It is not expected that accidental intake of petals of carnation IFD-26407-2 would contribute 
substantially to the overall intake of anthocyanins from foods. Considering the scope of notification 
C/NL/09/02 and given that case reports of occupational allergies to carnations are rare, there are no 
indications that the genetic modification will increase the risk of allergy among those coming into 
contact with carnations. Considering the scope of notification C/NL/09/02 and the limited exposure 
scenarios expected, the EFSA GMO Panel identified no reasons for any safety concerns of carnation 
IFD-26407-2. 
Carnation IFD-26407-2 cut flowers have marginal viability, negligible pollen production and few or 
no viable seeds. However, in the very unlikely event of escape into the environment via pollen/seeds 
or rooted plants, the EFSA GMO Panel considers that carnation IFD-26407-2 would not show 
enhanced fitness characteristics, except when exposed to sulfonylurea herbicides. Considering the 
scope of notification C/NL/09/02 and the low level of exposure to the environment, interactions with 
the biotic and abiotic environment are not considered to be relevant issues by the EFSA GMO Panel. 
The EFSA GMO Panel also concludes that the unlikely, but theoretically possible, horizontal gene 
transfer of recombinant genes from carnation IFD-26407-2 to environmental bacteria does not give 
rise to environmental safety concerns. The scope of the PMEM plan provided by the notifier is in line 
with the intended use of carnation IFD-26407-2. The EFSA GMO Panel agrees with the general 
methods and approaches, including reporting intervals, proposed by the notifier in its PMEM plan. 
In the light of the scope of notification C/NL/09/02 (import, distribution and retailing in the EU of 
carnation IFD-26407-2 cut flowers for ornamental use only), the EFSA GMO Panel concludes that 
there is no scientific reason to consider that the placing on the market of the GM carnation IFD-26407-
2 will cause any adverse effects on human health or the environment. 
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1. Introduction 
Carnation IFD-26407-2 is a genetically modified (GM) variety of Dianthus caryophyllus L. used as a 
decorative plant species. The dark mauve colour of the flowers results from the expression of two 
newly introduced genes encoding cytochrome b5 (cytb5) and flavonoid 3′,5′-hydroxylase (f3′5′h) 
which, together with endogenous genes in the anthocyanin biosynthesis pathway, enable the 
biosynthesis of delphinidin in the petals. Carnation IFD-26407-2 also contains a mutated herbicide 
tolerance als gene coding for an acetolactate synthase (ALS) variant protein, used to facilitate the 
selection of GM shoots during the genetic transformation process. 
In the present scientific opinion, the GM carnation IFD-26407-2 is evaluated by the Scientific Panel 
on Genetically Modified Organisms of the European Food Safety Authority (EFSA GMO Panel) in the 
light of the scope of notification C/NL/09/02 (import, distribution and retailing in the European Union 
(EU) of GM carnation cut flowers for ornamental use only). 
Therefore, the EFSA GMO Panel evaluated the safety of carnation IFD-26407-2 for humans 
considering three possible routes of exposure through (1) dermal contact, (2) inhalation and (3) 
accidental oral intake
5
. Owing to the scope of this notification, the EFSA GMO Panel did not assess 
the possible consequences of the intentional consumption of GM carnations by humans
6
. In relation to 
animals, both intentional and accidental oral intake were excluded from this opinion, as carnation IFD-
26407-2 is not expected to enter the feed chain or to be accidentally consumed in the field (cultivation 
being excluded from the scope) (EFSA, 2009a). 
Moreover, considering the scope of this notification, a very limited environmental exposure with 
respect to viable plant parts of the GM carnation is expected. Hence, the environmental risk 
assessment (ERA) is mainly concerned with the consequences of exposure through: (1) unintended 
release into the environment of GM carnations obtained by vegetative multiplication, (2) pollen 
dispersal from GM cut flowers to other carnations and wild relatives, (3) dispersal of seeds produced 
by GM cut flowers and possible progeny, and (4) discarded GM carnation cut flowers resulting in 
possible exposure of environmental bacteria to recombinant DNA. 
1.1. Background and Terms of Reference as provided by requestor 
In July 2009, the European Commission received the full notification (reference C/NL/09/02), together 
with the positive assessment report from the competent authority of the lead Member State, The 
Netherlands. 
In accordance with Directive 2001/18/EC
7
, the notification was then transmitted to the competent 
authorities of other Member States. Some of them raised comments and objections during the statutory 
60-day consultation period. The notifier, Florigene, provided the Member States with additional 
information in response to those comments and objections. However, some Member States maintained 
their reservations at the end of the additional 45-day consultation period, in which case, the European 
Commission is required to follow the procedure of Article 18(1) of Directive 2001/18/EC. In 
accordance with Article 18(1), the European Commission therefore consulted the EFSA GMO Panel 
for a scientific opinion. 
Against this background, the EFSA GMO Panel identified mainly general comments rather than 
reasoned objections as in the sense of Directive 2001/18/EC. Moreover, concerns raised by Member 
States that relate to, for example, traceability, labelling, socio-economics, molecular detection 
methodologies and their validation fall outside the remit of EFSA or its GMO Panel. 
                                                     
5 Accidental oral intake should be considered as unintentional, infrequent and/or of relatively short duration. 
6 The EFSA GMO Panel is aware of a food habit in certain populations to intentionally consume carnation petals as garnish; 
however, this intentional use is outside the scope of this notification. 
7 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the 
environment of genetically modified organisms and repealing Council Directive 90/220/EEC. OJ L 106, 17.4.2001, p. 1–
39.  
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EFSA is requested, in accordance with Article 28 of Directive 2001/18/EC, to provide a scientific 
opinion as to whether there is any scientific reason to believe that the placing on the market of the GM 
carnation line IFD-26407-2 for import is likely to cause any adverse effects on human health and the 
environment within the scope of Directive 2001/18/EC. 
2. Data and methodologies 
2.1. Data 
The present evaluation of the safety of the GM carnation IFD-26407-2 by the EFSA GMO Panel is 
based on the information provided in notification C/NL/09/02, including additional information
8
 
provided by the notifier, the assessment report of the Dutch competent authority, the concerns raised 
by Member States, relevant scientific publications and the experience gained in assessing GM 
carnations with similar traits (EFSA, 2006a, 2008; EFSA GMO Panel, 2014). 
2.2. Methodologies 
The EFSA GMO Panel performed its risk assessment in accordance with the principles of its guidance 
documents on the risk assessment of GM plants for non-food or non-feed purposes (EFSA, 2009a) and 
on the environmental risk assessment (ERA) of GM plants (EFSA GMO Panel, 2010). 
3. Assessment 
3.1. Molecular characterisation 
3.1.1. Concerns raised by Member States 
No objection raised by any Member State remained at the end of the 45-day Member States’ 
consultation period. Therefore, notwithstanding its own risk analysis, the EFSA GMO Panel had no 
specific concerns to address from the Member States on the molecular characterisation of GM 
carnation IFD-26407-2. 
3.1.2. Evaluation of relevant scientific data 
3.1.2.1. Transformation process and vector constructs 
To develop line IFD-26407-2, carnation variety Cerise Westpearl (CW) was transformed using 
disarmed Agrobacterium tumefaciens (also known as Rhizobium radiobacter) strain AGL0, which 
carried the transformation vector pCGP2355. 
The transformation vector pCGP2355 contained the following expression cassettes, needed to obtain 
the desired flower colour: 
1. the cytochrome b5 (cytb5) cassette, consisting of the promoter fragment from Antirrhinum 
majus chalcone synthase (CHS) gene, the cytb5 (difF) complementary DNA (cDNA) from 
Petunia × hybrida and the terminator sequence of a gene encoding a Petunia × hybrida 
putative phospholipid transfer protein homologue; 
2. the flavonoid 3′,5′-hydroxylase (f3′5′h) cassette, consisting of a chimeric f3′5′h gene 
constructed from the Petunia × hybrida f3′5′h cDNA, and the promoter and terminator 
fragments of a Dianthus caryophyllus anthocyanidin synthase (ans) gene. 
These two cassettes were inserted into the plant genome to obtain the desired flower colour. In 
addition, the vector pCGP2355 contained the acetolactate synthase cassette (als), consisting of the 
Cauliflower mosaic virus (CaMV) 35S promoter, and the coding region and the terminator sequence 
                                                     
8 See section ‘Documentation provided to EFSA’ below. 
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from als from the SuRB locus of Nicotiana tabacum. Acetolactate synthase provided tolerance to 
sulfonylurea herbicides, which was used as a marker trait in the selection of transformants. 
3.1.2.2. Transgene constructs in the genetically modified plants 
Carnation IFD-26407-2 contains one insert consisting of the transfer DNA (T-DNA) region of the 
transformation vector pCGP2355. Southern blot and polymerase chain reaction (PCR) analyses 
indicated that no plasmid backbone sequences had been integrated into carnation IFD-26407-2. The 
sequences of the insert and the flanking regions were provided. 
Bioinformatic analysis of the 5′ and 3′ flanking regions did not reveal disruption of known endogenous 
genes. 
In order to assess if the open reading frames (ORFs) present within the insert and spanning the 
junction sites give rise to any safety issues, their putative translation products were compared to 
appropriate databases for similarities to known allergens and toxins by using suitable algorithms. 
There were no significant hits with known toxins. By using an 80-amino-acid sliding window 
approach, a 35 % sequence identity was found within the newly expressed protein ALS with a 
Davidiella tassiana protein (see section 3.3.2.2). By using the same approach, identity of over 35 % 
was found with allergen ‘Amb a 4’ from common ragweed Ambrosia artemisiifolia for ORF 5.211 
within the insert. The putative translation product of ORF 5.211 is a 110-amino-acid sequence, 
generated from the reverse strand. The sequence corresponds to a section of the als gene encoded by 
the forward strand of the als gene cassette. Considering that ORF 5.211 is not in the codon frame 
intended to be expressed and does not include an ATG start codon, the likelihood that it is both 
transcribed and translated in carnation IFD-26407-2 is negligible. Furthermore, northern blot analysis 
did not reveal any other bands than the one expected for als. Searches of eight contiguous amino acids 
showed identity to a subtilisin protease allergen in Bacillus licheniformis for ORF 6.114 within the 
insert, putatively encoding a 25-amino-acid peptide. Considering that ORF 6.114 is not on the DNA 
strand of the insert intended to be transcribed and does not include an ATG, the likelihood that it is 
both transcribed and translated in carnation IFD-26407-2 is negligible. 
3.1.2.3. Information on the expression of the insert 
The presence of transcripts corresponding to f3′5′h, cytb5 and als genes in the petals was demonstrated 
using northern blot analysis. Confirmation of the functionality of the f3′5′h and cytb5 genes and of the 
production of delphinidin in petals was obtained visually from the flower colour, as well as from 
metabolite analysis using high-performance liquid chromatography (HPLC). Tolerance to sulfonylurea 
herbicides indicates the activity of the ALS protein. 
3.1.2.4. Inheritance and stability of the inserted DNA 
Carnation IFD-26407-2 was propagated vegetatively from January 2005 to September 2008, which 
represents multiple cycles of propagation. Furthermore, during 2007–2013, plants were cultivated in a 
field trial in Colombia and there were no reported incidents of flower colour change that would 
indicate genetic instability. 
3.1.3. Conclusion 
The molecular characterisation data establish that the carnation line IFD-26407-2 contains one insert, 
consisting of three expression cassettes responsible for the intended traits, i.e. dark mauve flower 
colour from the cytb5 and f3′5′h cassettes and herbicide tolerance by the mutated als gene. 
The results of bioinformatic analyses of the insert and flanking regions in carnation IFD-26407-2 did 
not indicate relevant similarities with known toxins. Identities with allergens were found in putative 
translation products of ORFs newly created by the genetic modification, but the likelihood that they 
are both transcribed and translated in carnation IFD-26407-2 is negligible. Sequence identity was 
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found between the newly expressed protein ALS and an allergen from Davidiella tassiana. The safety 
relevance of this sequence identity is assessed in section 3.3.2.2. 
3.2. Comparative analysis 
3.2.1. Concerns raised by Member States 
No objection remained among Member States concerning the comparative analysis of GM carnation 
IFD-26407-2 at the end of the 45-day Member States’ consultation period. 
3.2.2. Evaluation of relevant scientific data 
Considering that there is no history of the use of carnations as food or feed to a significant degree, that 
the safety of carnations per se has never been assessed for food/feed uses and that the compositional 
profile of carnations is not known, the comparative compositional assessment as defined in the EFSA 
guidance documents (EFSA, 2006b; EFSA GMO Panel, 2011a) could not be applied to identify 
possible unintended effects in carnation IFD-26407-2 (see section 1 for further details). 
3.2.2.1. Choice of comparator 
Carnation IFD-26407-2 was compared with the non-GM carnation variety Cerise Westpearl (CW) 
which was the variety of carnation that was transformed to establish carnation IFD-26407-2. Carnation 
CW is characterised by cerise petals. 
3.2.2.2. Compositional analysis 
The contents of the anthocyanin colour pigments delphinidin, cyanidin and pelargonidin were 
determined in acetonitrile extracts of freeze-dried petals using HPLC in accordance with the method of 
Fukui et al. (2003). As these anthocyanins occur as glycosylated and/or acylated compounds in the 
plant, the analytical method used a hydrolysis step converting the pigments into their aglycones, 
allowing the determination of total delphinidin, total cyanidin and total pelargonidin and not the 
specific compounds in the plant. 
The cerise flower petals of the comparator CW contained only cyanidin pigments (0.01 mg/g fresh 
weight (fw)) and pelargonidin pigments (1.06 mg/g fw), whereas those of the GM mauve-coloured 
carnation IFD-26407-2 contained delphinidin (2.87 mg/g fw), cyanidin (0.37 mg/g fw) and 
pelargonidin (0.01 mg/g fw). Delphinidin-based pigments were not observed in other plant tissues of 
the transgenic plants (stem, nodes, leaves and roots). This has been confirmed by HPLC studies of leaf 
and root material. 
The altered levels and types of anthocyanins in carnation IFD-26407-2 account for the intended 
phenotypic changes in the flower colour. The altered flower colour is not expected to influence the 
risk scenario of accidental intake of the GM carnation. 
3.2.2.3. Morphological traits and genetically modified phenotype 
In total, 18 morphological characteristics were analysed in carnation IFD-26407-2 and its comparator 
(carnation CW) grown in a field trial in Australia, during the 2007–2008 season. An analysis of 
variance (ANOVA) identified eight significant differences between the GM carnation and its 
comparator. Thus, carnation IFD-26407-2 had a lower number of internodes per stem, a thinner stem 
at the fifth node, shorter leaves at the third node, an increased calyx diameter, longer styles, less viable 
anthers, more filaments and a reduced filament length. In addition, the average number of days to 
flowering was shorter in carnation IFD-26407-2 than in carnation CW: 131 and 146 days, respectively. 
3.2.3. Conclusion 
Considering the scope of the notification and focusing on the limited information provided by the 
notifier, the EFSA GMO Panel is of the opinion that the altered flower colour and the differences 
Scientific Opinion on GM carnation IFD-26407-2 for import of cut flowers in EU 
 
EFSA Journal 2014;12(12):3935 9 
observed for some morphological characteristics are not expected to influence the risk scenario of 
accidental intake of the GM carnation. The relevance of the observed morphological differences for 
their potential environmental impacts is further assessed in section 3.4.3.1. 
3.3. Food/feed safety assessment 
3.3.1. Concerns raised by Member States 
No objection remained among Member States concerning the safety assessment of GM carnation IFD-
26407-2 for humans at the end of the 45-day Member States’ consultation period. 
The possible need for an acute toxicity study with whole plant extracts to support the assessment of 
this GM carnation in relation to accidental intake by humans was suggested by a Member State and 
was also discussed by the EFSA GMO Panel. Such a study was not considered necessary, as the safety 
assessment is sufficiently supported by the available data (see sections 3.3.2.1(a) and (b)). 
3.3.2. Evaluation of relevant scientific data 
3.3.2.1. Toxicology 
(a) Toxicological assessment of newly expressed proteins 
Bioinformatic analyses of the amino acid sequences of the newly expressed proteins in carnation IFD-
26407-2 reveal no significant similarities to known toxins to humans. 
The EFSA GMO Panel has previously assessed the safety of the ALS and F3′5′H proteins and no 
reasons for concern were identified (EFSA, 2006a, 2008). 
(b) Toxicological assessment of new constituents other than proteins 
The anthocyanins delphinidin and cyanidin are present in carnation IFD-26407-2 at higher levels than 
in the non-GM carnation. These anthocyanins can also be found in many foods and in some of them at 
much higher concentrations than in the petals of carnation IFD-26407-2. Particularly high 
concentrations can be found, for example, in blackcurrants, aubergines, blueberries and red grapes 
(Cacho et al., 1992). According to Regulation 1333/2008
9
 on food additives, anthocyanins (E 163) are 
authorised food additives in the EU. Anthocyanins have been evaluated by the Scientific Committee 
on Foods (SCF), which concluded that anthocyanins prepared by physical processes from natural 
foods are acceptable for use in food without further investigations. The SCF indicated that 
anthocyanins derived from natural sources are only acceptable as food additives if the quantities 
ingested do not differ substantially from the amounts that are likely to be ingested as a result of the 
normal consumption of the foods in which they occur naturally (SCF, 1975). In the re-evaluation of 
anthocyanins, the Scientific Panel on Food Additives and Nutrient Sources Added to Food of the 
EFSA (EFSA ANS Panel, 2013) concluded that, provided that exposure from the use of food colours 
is comparable to that from the diet, the conclusion on safety in the 1975 opinion would still apply to 
anthocyanins extracted by aqueous processes from edible fruits and vegetables. 
It is not expected that the accidental intake of petals of carnation IFD-26407-2 would contribute 
substantially to the overall intake of anthocyanins from foods. Therefore, the EFSA GMO Panel sees 
no reason for concern regarding the presence of delphinidin and cyanidin in petals of carnation IFD-
26407-2. 
In addition, the notifier also performed a study on gene mutations in bacteria using Salmonella 
enterica Typhimurium (Ames test) with water extracts of leaves or petals of carnation IFD-26407-2 
                                                     
9 Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives. OJ 
L 354, 31.12.2008, p. 16–33. 
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and the control carnation CW. The water extracts did not show mutagenic activity under the conditions 
of the assay. 
(c) Toxicological assessment of the whole genetically modified plant 
Given that carnation IFD-26407-2 is not intended for human consumption as food but is intended for 
ornamental use only, the EFSA GMO Panel considered the possible effects of the genetic modification 
on human health in the case of accidental intake (EFSA, 2009a). Considering the assessment of the 
newly expressed proteins (section 3.3.2.1(a)) and of the new constituents other than proteins (section 
3.3.2.1(b)), the EFSA GMO Panel identified no reasons for concern. 
3.3.2.2. Allergenicity 
(a) Allergenicity assessment of newly expressed proteins 
Bioinformatic analyses of the amino acid sequence of the newly expressed proteins in carnation IFD-
26407-2 using the criterion of more than 35 % identity in a segment of 80 or more amino acids (Codex 
Alimentarius, 2003) revealed no significant similarities to known allergens. In addition, the notifier 
performed analyses searching for matches of eight contiguous identical amino acid sequences between 
these newly expressed proteins and known allergens, which confirmed the outcome of the above-
mentioned bioinformatic analyses showing no similarities to known allergens. 
The EFSA GMO Panel has previously assessed the safety of the ALS and F3′5′H proteins and no 
reasons for concern were identified (EFSA, 2006a, 2008). 
The EFSA GMO Panel noted that 35 % sequence identity over a window of 80 amino acids between 
the ALS protein and an allergen from Davidiella tassiana was reported. However, this hit was not 
considered relevant because the percentage of identity was not greater than 35 % and, in addition, a 
high E-value
10
 was seen. 
(b) Allergenicity assessment of the whole genetically modified plant 
Occupational allergy (dermal and respiratory allergy) to carnations in workers handling cut 
flowers/carnations over a long time has been described (Sanchez-Guerrero et al., 1999; Cistero-
Bahima et al., 2000; Sanchez-Fernandez et al., 2004; Stefanaki and Pitsios, 2008)
11
. This allergy could 
be caused by the flower, by mites such as Tetranychus urticae infesting carnations or by both 
simultaneously. Nevertheless, case reports of occupational allergies to carnations are rare. 
More recently, a case report of an individual with a respiratory allergy to carnations with no 
occupational exposure was published (Brinia et al., 2013)
11
. 
According to the notifier, no adverse reactions (including allergenicity or contact dermatitis) to GM 
carnation IFD-26407-2 cut flowers used for ornamental purposes have been reported in the 
populations handling the flowers (growers, distributors and purchasers) where it is produced and/or 
marketed
11
. 
Considering the scope of notification C/NL/09/02 and given that case reports of occupational allergies 
to carnations are rare, there are no indications that the genetic modification will increase the risk of 
allergy among those coming into contact with carnations. 
3.3.3. Conclusion 
Carnation flowers have a long history of use as ornamentals. Carnation IFD-26407-2 differs from the 
non-GM carnation in that it synthesises anthocyanins, mainly delphinidin and cyanidin, in the petals, 
                                                     
10 An alignment derived from a FASTA search of a database is accompanied with an E-value, which represents the number of 
times the corresponding alignment score is expected at chance. 
11 Additional information 28 August 2014. 
Scientific Opinion on GM carnation IFD-26407-2 for import of cut flowers in EU 
 
EFSA Journal 2014;12(12):3935 11 
which confer a mauve colour to the flowers. Delphinidin and cyanidin are common pigments in many 
ornamental flowers and food plants such as red grapes, blackcurrants, aubergines and blueberries. It is 
not expected that accidental intake of petals of carnation IFD-26407-2 would contribute substantially 
to the overall intake of anthocyanins from foods. 
Considering the scope of notification C/NL/09/02 and given that case reports of occupational allergies 
to carnations are rare, there are no indications that the genetic modification will increase the risk of 
allergy among those coming into contact with carnations. 
Considering the scope of notification C/NL/09/02 and the limited exposure scenarios expected, the 
EFSA GMO Panel identified no reasons for any safety concerns of carnation IFD-26407-2. 
3.4. Environmental risk assessment and post-market environmental monitoring plan 
3.4.1. Concerns raised by Member States 
Some Member States expressed concerns related to the possible illegal propagation of carnation IFD-
26407-2 through vegetative multiplication by individuals. More details on the methods and 
implementation of the post-market environmental monitoring (PMEM) plan were requested by some 
Member States. 
3.4.2. Evaluation of relevant scientific data 
Considering the scope of notification C/NL/09/02, there will be very limited environmental exposure 
with respect to viable plant parts of the GM carnation. The ERA is mainly concerned with the 
consequences of exposure through: (1) unintended release into the environment of GM carnations 
obtained by vegetative multiplication, (2) pollen dispersal from GM cut flowers to other carnations 
and wild relatives, (3) dispersal of seeds produced by GM cut flowers and possible progeny and (4) 
discarded GM carnation cut flowers resulting in possible exposure of environmental bacteria to 
recombinant DNA. 
3.4.3. Environmental risk assessment12 
3.4.3.1. Potential unintended effects on plant fitness due to the genetic modification 
Carnation is the common name of Dianthus caryophyllus (i.e. cultivated carnation). Members of the 
genus Dianthus, including wild and domesticated species, are fairly diverse, as their origins range 
from southern Russia to the Alpine region of Greece and the Auvergne mountains of France. Dianthus 
spp. are adapted to the cooler Alpine regions of Europe and Asia, and are also found in Mediterranean 
coastal regions. D. caryophyllus is a widely cultivated ornamental plant in Europe both in glasshouses 
and outdoors (i.e. in Italy and Spain) and is occasionally naturalised in some Mediterranean countries 
but appears to be restricted to the coastal Mediterranean regions of Greece, Italy, Sicily, Corsica and 
Sardinia (Tutin et al., 1993). 
Although Dianthus spp. do not spread vegetatively through organs such as bulbs, stolons or rhizomes, 
the cultivated carnation can be vegetatively propagated to produce plants for cut flower production. 
Cuttings are taken from ‘mother plants/stems’ which are continually pruned to produce a large number 
of vegetative cuttings from axillary buds. These cuttings are rooted in conditions of high humidity 
after treatment to encourage root growth. Rooted plants may be planted in soil or grown 
hydroponically, and are kept for one to two years. Flowers are produced in flushes, beginning three to 
five months after rooted cuttings are planted. 
The majority of Dianthus spp. is self-sterile because the stigma is not receptive to pollen until one 
week or more after anthers have shed pollen. Cultivated carnations require pollination by hand to set 
seed (Bird, 1994). As a result of the long history of use of vegetative propagation and selection for 
                                                     
12 Notification C/NL/09/02, Section B. 
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flower characteristics, the carnation produces only a negligible amount of pollen, and consequently 
seed set is low or absent (Galbally and Galbally, 1997). The quantity and quality of pollen varies with 
the cultivar (Kho and Baer, 1973; Galbally and Galbally, 1997). Carnation pollen is heavy and sticky 
and has low viability. Wind plays little role in pollen dispersal (OGTR, 2006). In the wild, cross-
pollination of Dianthus spp. is by insect pollinators, in particular by Lepidoptera, which have 
probosces of sufficient length to reach the nectaries at the base of the flowers. 
Carnation IFD-26407-2 has a modified flower colour resulting from the expression of two newly 
introduced genes encoding cytb5 and f3′5′h, which, together with endogenous genes in the 
anthocyanin biosynthesis pathway, enable the biosynthesis of delphinidin in the petals. These 
anthocyanins are also widely found, for example, in flowers of the genus Petunia (Ando et al., 1999), 
Rosa (Biolley and Jay, 1993) or Chrysanthemum (Schwinn et al., 1993; Andersen et al., 2000). There 
is no evidence that the presence of delphinidin and cyanidin would lead to effects on plant fitness. 
Carnation IFD-26407-2 contains a mutated als gene conferring tolerance to sulfonylurea herbicides. 
Given that the ALS enzyme is needed for the biosynthesis of some branched-chain amino acids such 
as isoleucine, ALS-inhibiting herbicides cause the death of the plant by interfering with this 
biosynthesis pathway. In relation to this, Tranel and Wright (2002) reported that tolerance to ALS-
inhibiting herbicides was widespread among weeds and was mostly due to a mutated als gene. In 
addition, the ALS-tolerant biotype was shown to be less sensitive to feedback inhibition by branched-
chain amino acids. This results in greater accumulation of branched-chain amino acids in tolerant 
biotypes, which may allow seeds from tolerant biotypes to germinate more rapidly, especially in cool 
temperatures. This may indicate a possible change in behaviour of the tolerant plants in the absence of 
herbicide selection in the very unlikely event of escape into the environment. Wild Dianthus 
populations exhibit a diversity of phenotypes exploiting niches in a wide geographical range in Europe 
(Tutin et al., 1993). The EFSA GMO Panel considered that a small change in seed germination 
characteristics induced by ALS tolerance is unlikely to be outside the current range of seed 
germination characteristics currently expressed by non-GM carnations and thus is unlikely to have an 
ecological impact. 
In the very unlikely event of gene transfer to cultivated carnations, they may express the mutated als 
gene conferring tolerance to sulfonylurea herbicides. This could result in a possible fitness advantage 
and higher weediness of the tolerant plants in the presence of these herbicides and those with a similar 
mode of action. However, these herbicides are not known to be used
13
 on cultivated carnations. Such 
herbicide-tolerant plants can be managed by a range of measures (Tranel and Wright, 2002). There is 
no evidence that the traits introduced by the genetic modification result in increased persistence and 
invasiveness of a plant species. 
In general, carnation varieties compete poorly outside their cultivated environment. In addition, 
carnation varieties do not show weedy characteristics. In notification C/NL/09/02, the notifier 
presented morphological or phenotypic data gathered from a field trial conducted in Australia during 
the 2007–2008 season (see section 3.2.2.3)14. A total15 of 18 morphological characteristics were 
evaluated for the GM carnation, in comparison with the parental line CW. Statistically significant 
differences were observed between the GM carnation and its parental line for 8 out of the 18 
characteristics studied. Carnation IFD-26407-2 had a lower number of internodes per stem, a thinner 
stem at the fifth node, shorter leaves at the third node, an increased calyx diameter, longer styles, less 
viable anthers, more filaments and a reduced filament length. The notifier attributed these variations in 
morphological characters to environmental factors. The notifier also reported from the 2007–2008 
Australian field trial a lower average number of days to flowering for the GM carnation than its 
                                                     
13 See additional information provided by the notifier to Member States after the 60-day consultation period. 
14 Notification C/NL/09/02, Attachment A12. 
15 Plant height (mm), number of internodes per stem, length of fifth node (mm), thickness of fifth node (mm), leaf length of 
third node from the top (mm), height of corolla (mm), flower diameter (mm), calyx diameter (mm), calyx length (mm), 
number of lobes per calyx, number of petals per flower, petal length (mm), petal width (mm), number of styles, style 
length (mm), number of viable anthers, filament length (mm), number of filaments. 
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parental line. A reduction in the number of days to flowering would not bring any selective advantage 
to the GM carnation or its progeny and therefore could not be associated with a different or increased 
fitness potential. The EFSA GMO Panel is of the opinion that, owing to their morphological nature, 
these characteristics for which differences were observed are unlikely to affect the survival, 
establishment and fitness of the GM carnation. 
Moreover, the EFSA GMO Panel is not aware of any scientific reports of increased spread and 
establishment of (GM) carnations or of any change in survival capacity, including overwintering 
(COGEM report
16
; EFSA, 2006a, 2008). In addition, D. caryophyllus has been imported into all EU 
countries as a garden ornamental plant and cut flower for many decades and EFSA is not aware of any 
reports of feral populations that have established outside of cultivation. 
In order to assess the likelihood of unintended effects on the environment, the EFSA GMO Panel 
followed a weight-of-evidence approach in collating and assessing appropriate information from 
various data sources (e.g. molecular data, available phenotypic data from a field trial performed by the 
notifier, literature and previous evaluations of similar transformation events (EFSA, 2006a, 2008; 
EFSA GMO Panel, 2014)). Therefore, considering the scope of notification C/NL/09/02 and the data 
available, the EFSA GMO Panel considered that there would be very little exposure of other Dianthus 
populations and no changes in plant characteristics of any ecological significance. Carnation IFD-
26407-2 plants would show changed fitness characteristics only when exposed to sulfonylurea 
herbicides, but these herbicides are not used in carnation cultivation or in habitats where wild 
Dianthus spp. might occur. The EFSA GMO Panel also concludes that the propagation of the GM 
carnation (e.g. rooting) by individuals cannot be excluded. However, should this occur, carnation IFD-
26407-2 would not show any potential for increased survival, fitness or weediness compared with its 
parental line. 
3.4.3.2. Potential for gene transfer 
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic material, 
through either horizontal gene transfer of DNA or vertical gene flow via seed dispersal and cross-
pollination. 
(a) Plant-to-bacteria gene transfer 
Considering the scope of notification C/NL/09/02, the ERA is concerned with exposure through 
discarded GM carnation cut flowers resulting in possible exposure of environmental bacteria to 
recombinant DNA. If accidental intake of these GM carnations by humans occurs
17
 (see section 3.3), it 
is likely to be at very low levels so that exposure of gastro-intestinal tract bacteria and microfloral 
decomposers of faecal material will be very low. 
Current scientific knowledge of recombination processes in bacteria indicates that horizontal transfer 
of non-mobile, chromosomally located DNA fragments between unrelated organisms (such as plants 
to microorganisms) is not likely to occur at detectable frequencies under natural conditions (see EFSA, 
2009b, for further details). 
Successful horizontal gene transfer would require the stable insertion of the transgene sequences into a 
bacterial genome and a selective advantage conferred to the transformed host. The only known 
mechanism that facilitates horizontal transfer of non-mobile, chromosomal DNA fragments to 
bacterial genomes is homologous recombination. This requires the presence of stretches of DNA 
sequences that are similar in the recombining DNA molecules and, in addition to substitutive gene 
replacement, facilitates the insertion of non-homologous DNA sequences if their flanking regions have 
sequence similarity with bacterial sequences in the recipient. 
                                                     
16 Available online: http://www.cogem.net/index.cfm/en/publications/publicatie/advisory-report-import-distribution-and-
retail-of-cut-flowers-with-modified-flower-colour-gm-carnation-shd-27531-4 
17 Accidental oral intake should be considered as unintentional, infrequent and/or of relatively short duration. 
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Carnation IFD-26407-2 does not contain genetic elements with identity or high similarity to those of 
bacteria. The recombinant genetic elements used for the construction of carnation IFD-26407-2 
originate from plants, i.e. Petunia, Antirrhinum, Dianthus and Nicotiana tabacum (tobacco) (for more 
details, see section 3.1.2.1). Owing to the absence of DNA with high similarity to bacteria, there is no 
indication of facilitated transfer of recombinant genes to bacteria when it is compared with the transfer 
of genes from non-GM carnations. Thus, based on the data provided by the notifier, no increased 
likelihood for horizontal gene transfer from carnation IFD-26407-2 to environmental bacteria is 
expected. The EFSA GMO Panel could not identify any selective advantage which would be provided 
to environmental bacteria when receiving the recombinant DNA of carnation IFD-26407-2. 
Therefore, considering the scope of notification C/NL/09/02, the EFSA GMO Panel concluded that the 
unlikely, but theoretically possible, horizontal gene transfer of recombinant genes from carnation IFD-
26407-2 to environmental bacteria does not give rise to environmental safety concerns. 
(b) Plant-to-plant gene transfer 
Considering the scope of notification C/NL/09/02, the ERA is mainly concerned with indirect 
exposure through (1) unintended release into the environment of GM carnations obtained by 
vegetative multiplication, (2) pollen dispersal from GM cut flowers to other carnations and wild 
relatives and (3) dispersal of seeds produced by GM cut flowers and possible progeny. 
Carnation IFD-26407-2 plants are imported as cut flowers and thus have no roots and only occasional 
vegetative buds. The cut stems with vegetative shoots could be propagated by rooting or by micro-
propagation. The latter is a multiplication technique applied in the laboratory which requires particular 
expertise and adequate material for successful tissue culture. The EFSA GMO Panel is of the opinion 
that this technique is unlikely to be used by individuals (e.g. amateur gardeners) to propagate GM 
carnations. However, the GM carnation could be propagated by rooting and then released into the 
environment (e.g. gardens). The EFSA GMO Panel therefore considered the consequences of such 
potential releases (see section 3.4.3.1) and concluded that, should this occur, carnation IFD-26407-2 
would not show any potential for increased survival, fitness or weediness compared with its parental 
line. 
Wind plays little role in pollen dispersal of Dianthus spp. (OGTR, 2006). In the wild, cross-pollination 
of Dianthus spp. is by insect pollinators, in particular by Lepidoptera, which have probosces of 
sufficient length to reach the nectaries at the base of the flowers. However, the GM carnation has 
double flowers with a high density of petals. These obstruct insect pollinators from probing the 
flowers to reach the nectaries and therefore discourage insect pollinator activity and limit the amount 
of pollen they collect and transfer to other flowers. The EFSA GMO Panel is of the opinion that the 
potential spread of pollen of the GM carnation by Lepidoptera to wild Dianthus spp. cannot be 
eliminated but is highly unlikely to occur and, if it did occur, it is very unlikely that viable hybrids 
would be produced, survive and cause adverse environmental effects (see section 3.4.3.1). 
Moreover, the reproductive biology of Dianthus (OGTR, 2006) and the information provided by the 
notifier suggest that pollen production by flowers and pollen viability are low. Moreover, in 
notification C/NL/09/01, the notifier pointed out that ‘flowers must be harvested in tight bud (or 
closed bud for spray types) for distribution and marketing’, which rules out pollination during 
production, but suggests it could occur post-marketing. However, the data indicate that pollen transfer 
to other carnations is very unlikely to occur owing to very low fertility levels in most carnations. In 
addition, viable seed production of cut flowers is very unlikely and has not been observed so far with 
carnation IFD-26407-2, most probably because of its limited life time (i.e. three weeks) in comparison 
with the time needed for complete seed development (i.e. five weeks). 
The EFSA GMO Panel also considered the possibility of natural exchange of genetic material with 
other carnation varieties, Dianthus caryophyllus L., and wild Dianthus species. Although hybridisation 
is mentioned in some floristic surveys, the EFSA GMO Panel is not aware of reports of gene flow 
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between cultivated carnations and wild Dianthus spp. in the literature. The probability of spontaneous 
hybridisation between GM carnations and other cultivated carnations or wild relatives, and then the 
establishment of viable hybrids, is considered to be very low. 
Therefore, taking account of the very low potentials for hybridisation and/or seed production of (GM) 
carnations, the EFSA GMO Panel concludes that plant-to-plant gene transfer of the introduced genes 
is very unlikely and, if it did occur, it is unlikely to result in viable seed production leading to adverse 
environmental effects. 
3.4.3.3. Potential interactions of the genetically modified plant with target organisms 
Considering the scope of notification C/NL/09/02 and the absence of target organisms, potential 
interactions of the GM plant with target organisms were not considered a relevant issue by the EFSA 
GMO Panel. 
3.4.3.4. Potential interactions of the genetically modified plant with non-target organisms 
Considering the scope of notification C/NL/09/02 and the low level of exposure to the environment, 
potential interactions of the GM plant with non-target organisms were not considered a relevant issue 
by the EFSA GMO Panel. 
3.4.3.5. Potential interactions with the abiotic environment and biogeochemical cycles 
Considering the scope of notification C/NL/09/02 and the low level of exposure to the environment, 
potential interactions with the abiotic environment and biogeochemical cycles were not considered a 
relevant issue by the EFSA GMO Panel. 
3.4.4. Post-market environmental monitoring18 
According to Annex VII of Directive 2001/18/EC, the objectives of a post-market environmental 
monitoring (PMEM) plan are: (1) to confirm that any assumption regarding the occurrence and impact 
of potential adverse effects of the GMO or its use in the ERA are correct; and (2) to identify the 
occurrence of adverse effects of the GMO or its use on human health or the environment that were not 
anticipated in the ERA. 
Monitoring is related to risk management, and thus a final adoption of the PMEM plan falls outside 
the mandate of EFSA. However, the EFSA GMO Panel gives its opinion on the scientific content of 
the PMEM plan provided by the notifier (EFSA GMO Panel, 2011b). The potential exposure to the 
environment of carnation IFD-26407-2 would be mainly through (1) unintended release into the 
environment of GM carnations obtained by vegetative multiplication, (2) pollen dispersal from GM 
cut flowers to other carnations and wild relatives, (3) dispersal of seeds produced by GM cut flowers 
and possible progeny and (4) discarded GM carnation cut flowers resulting in possible exposure of 
environmental bacteria to recombinant DNA. The scope of the PMEM plan provided by the notifier is 
in line with the restricted intended use of GM carnation cut flowers. 
The PMEM plan proposed by the notifier includes (1) a questionnaire for the European importers and 
operators, including questions on unexpected adverse effects and ‘illegal growing’; (2) the 
involvement of existing networks (i.e. national plant protection services); and (3) the consultation of a 
network of European taxonomists, botanists and breeders to report on any wild populations or unusual 
Dianthus hybrids that might originate from the GM carnation. In addition, the notifier plans to survey 
the production sites in Colombia and Ecuador to report diverse observations, including adverse effects 
and the incidence of genetic off-types. The notifier proposes to submit a PMEM report on an annual 
basis. The report will include, for example, the number of imported GM cut flowers and a report of the 
identified hybrids and of feral carnation populations, if any. 
                                                     
18 See notification C/NL/09/02, Section D. 
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The EFSA GMO Panel is of the opinion that the scope of the PMEM plan proposed by the notifier is 
in line with the restricted intended use of carnation IFD-26407-2, as the ERA did not cover cultivation 
and identified no potential adverse environmental effects. No case-specific monitoring is required. 
3.4.5. Conclusion 
Carnation IFD-26407-2 cut flowers have marginal viability, negligible pollen production and few or 
no viable seeds. However, in the very unlikely event of escape into the environment via pollen/seeds 
or rooted plants, the EFSA GMO Panel considers that carnation IFD-26407-2 would not show 
enhanced fitness characteristics, except when exposed to sulfonylurea herbicides. Considering the 
scope of notification C/NL/09/02 and the low level of exposure to the environment, interactions with 
the biotic and abiotic environment are not considered to be relevant issues by the EFSA GMO Panel. 
The EFSA GMO Panel also concluded that the unlikely, but theoretically possible, horizontal gene 
transfer of recombinant genes from carnation IFD-26407-2 to environmental bacteria does not give 
rise to environmental safety concerns. The scope of the PMEM plan provided by the notifier is in line 
with the intended use of carnation IFD-26407-2. The EFSA GMO Panel agreed with the general 
methods and approaches, including reporting intervals, proposed by the notifier in its PMEM plan. 
4. Conclusions 
In the light of the scope of notification C/NL/09/02 (import, distribution and retailing in the EU of 
carnation IFD-26407-2 cut flowers for ornamental use only), the EFSA GMO Panel concludes that 
there is no scientific reason to consider that the placing on the market of the GM carnation IFD-26407-
2 will cause any adverse effects on human health or the environment. 
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European Commission, and received from the European Commission on 4 April 2013. 
2. Letter from the European Commission, dated 4 April 2013, to the EFSA Executive Director 
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4. Letter from EFSA to the notifier, dated 24 July 2013, requesting additional information. 
5. Letter from the notifier to EFSA, received on 8 November 2013, providing additional information. 
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information. 
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9. Letter from the notifier to EFSA, received on 25 April 2014, providing additional information. 
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